Company Search:
Advanced Search
Sponsored Links
Processa Pharmaceuticals Inc Company Snapshot
Processa Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Processa Pharmaceuticals Inc with three other pharmaceutical manufacturers in North America: Elixxer Ltd of CANADA (2016 sales of 2,507.00 Canadian Dollars [US$1,883.53 ] ), Immune Therapeutics Inc ($3,463.00 ), and Calethos Inc ($3,666.00 ).

Sales Analysis. Sales fell dramatically in 2016: Processa Pharmaceuticals Inc reported sales of $5,000.00 for the year ending December of 2016. This represents a sharp decrease of 95.6% versus 2015, when the company's sales were $113,425.00 .
  Stock Performance Chart for Processa Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 8.39
(Figures in U.S. Dollars)
1 Week 10.4%   13 Weeks 2.4%  
4 Weeks n/a   52 Weeks -53.9%  
Processa Pharmaceuticals Inc Key Data:
  Ticker: PCSA Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 5,000
(Year Ending Jan 2017).
Employees: 13
  Currency: U.S. Dollars Market Cap: 46,266,210
  Fiscal Yr Ends: December Shares Outstanding: 5,514,447
  Share Type: Units Closely Held Shares: 3,631,420
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.